CA1232849A - Antigenes circulants de dirofilaria immitis, anticorps monoclonaux specifiques et methodes de preparation desdits anticorps et de detection desdits antigenes - Google Patents
Antigenes circulants de dirofilaria immitis, anticorps monoclonaux specifiques et methodes de preparation desdits anticorps et de detection desdits antigenesInfo
- Publication number
- CA1232849A CA1232849A CA000467019A CA467019A CA1232849A CA 1232849 A CA1232849 A CA 1232849A CA 000467019 A CA000467019 A CA 000467019A CA 467019 A CA467019 A CA 467019A CA 1232849 A CA1232849 A CA 1232849A
- Authority
- CA
- Canada
- Prior art keywords
- antigens
- immitis
- parasite
- antibody
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 182
- 102000036639 antigens Human genes 0.000 title claims abstract description 182
- 108091007433 antigens Proteins 0.000 title claims abstract description 182
- 241000243988 Dirofilaria immitis Species 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims abstract description 49
- 229940099686 dirofilaria immitis Drugs 0.000 title claims description 30
- 244000045947 parasite Species 0.000 claims abstract description 65
- 238000003556 assay Methods 0.000 claims abstract description 41
- 241001465754 Metazoa Species 0.000 claims abstract description 18
- 210000004369 blood Anatomy 0.000 claims abstract description 14
- 239000008280 blood Substances 0.000 claims abstract description 14
- 210000001124 body fluid Anatomy 0.000 claims abstract description 11
- 210000002966 serum Anatomy 0.000 claims description 33
- 210000004027 cell Anatomy 0.000 claims description 20
- 210000004408 hybridoma Anatomy 0.000 claims description 19
- 239000000284 extract Substances 0.000 claims description 17
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 16
- 238000000760 immunoelectrophoresis Methods 0.000 claims description 15
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 15
- 241000699670 Mus sp. Species 0.000 claims description 13
- 238000001962 electrophoresis Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- 210000004989 spleen cell Anatomy 0.000 claims description 11
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 10
- 230000004927 fusion Effects 0.000 claims description 10
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 230000000890 antigenic effect Effects 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 230000005764 inhibitory process Effects 0.000 claims description 8
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 241000243990 Dirofilaria Species 0.000 claims description 6
- 102000003886 Glycoproteins Human genes 0.000 claims description 6
- 108090000288 Glycoproteins Proteins 0.000 claims description 6
- 230000001900 immune effect Effects 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 230000003053 immunization Effects 0.000 claims description 5
- 238000013508 migration Methods 0.000 claims description 5
- 230000005012 migration Effects 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 4
- 239000003547 immunosorbent Substances 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 210000000952 spleen Anatomy 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 238000010367 cloning Methods 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 230000005294 ferromagnetic effect Effects 0.000 claims description 2
- 238000003306 harvesting Methods 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 claims 3
- 238000002965 ELISA Methods 0.000 claims 3
- 206010003445 Ascites Diseases 0.000 claims 1
- 239000011543 agarose gel Substances 0.000 claims 1
- 238000001311 chemical methods and process Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 11
- 210000004754 hybrid cell Anatomy 0.000 abstract description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 48
- 241001061260 Emmelichthys struhsakeri Species 0.000 description 30
- 208000015181 infectious disease Diseases 0.000 description 16
- 239000002953 phosphate buffered saline Substances 0.000 description 15
- 241000283973 Oryctolagus cuniculus Species 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000011324 bead Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000005406 washing Methods 0.000 description 7
- 241000282320 Panthera leo Species 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- 239000012894 fetal calf serum Substances 0.000 description 4
- 238000002523 gelfiltration Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 4
- 241000189162 Acanthocheilonema reconditum Species 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 102000006395 Globulins Human genes 0.000 description 3
- 108010044091 Globulins Proteins 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- 241000243985 Onchocerca volvulus Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000016784 immunoglobulin production Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001155 isoelectric focusing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000002042 onchocerciasis Diseases 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229960004319 trichloroacetic acid Drugs 0.000 description 3
- 241000272470 Circus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 201000006353 Filariasis Diseases 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- 208000030852 Parasitic disease Diseases 0.000 description 2
- 239000012506 Sephacryl® Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012133 immunoprecipitate Substances 0.000 description 2
- 238000001114 immunoprecipitation Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000010807 negative regulation of binding Effects 0.000 description 2
- 230000002560 nonimmunologic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241001315286 Damon Species 0.000 description 1
- 208000003917 Dirofilariasis Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 101710175243 Major antigen Proteins 0.000 description 1
- 206010027253 Meningitis pneumococcal Diseases 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010065081 Phosphorylase b Proteins 0.000 description 1
- 241000233870 Pneumocystis Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000989363 Stenolophus comma Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 230000001001 anti-filiarial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000003108 parasitologic effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 208000004593 pneumococcal meningitis Diseases 0.000 description 1
- 201000000317 pneumocystosis Diseases 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55711783A | 1983-12-01 | 1983-12-01 | |
| US557,117 | 1983-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1232849A true CA1232849A (fr) | 1988-02-16 |
Family
ID=24224112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000467019A Expired CA1232849A (fr) | 1983-12-01 | 1984-11-05 | Antigenes circulants de dirofilaria immitis, anticorps monoclonaux specifiques et methodes de preparation desdits anticorps et de detection desdits antigenes |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU582129B2 (fr) |
| CA (1) | CA1232849A (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4842999A (en) * | 1986-08-11 | 1989-06-27 | Adi Diagnostics Inc. | Canine heartworm vaccine and diagnostic test |
| WO1988001277A1 (fr) * | 1986-08-18 | 1988-02-25 | The Australian National University | Vaccin contre les parasites helminthes |
| NZ230773A (en) * | 1988-09-26 | 1993-04-28 | Biotech Australia Pty Ltd | Nematode antigenic peptides and vaccines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2430013A1 (fr) * | 1978-06-27 | 1980-01-25 | Sebia Sa | Systeme physico-biochimique pour la detection des substances, a activite antigenique |
| US4204989A (en) * | 1978-12-13 | 1980-05-27 | Merck & Co., Inc. | Isolation of hepatitis B e antigen |
| SE8405105L (sv) * | 1984-05-24 | 1985-11-25 | Damon Biotech Inc | Sett for screening av celler |
-
1984
- 1984-11-05 CA CA000467019A patent/CA1232849A/fr not_active Expired
- 1984-11-30 AU AU36095/84A patent/AU582129B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU3609584A (en) | 1985-06-06 |
| AU582129B2 (en) | 1989-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Avrameas | Coupling of enzymes to proteins with glutaraldehyde: use of the conjugates for the detection of antigens and antibodies | |
| JP3043999B2 (ja) | 排泄物検体中のｈ．ピロリ菌のイムノアッセイ | |
| US4839275A (en) | Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens | |
| JPH04212063A (ja) | 人間の肺腫瘍関連抗原に対する検定法及び試薬 | |
| US20250362290A1 (en) | Cho host cell protein assay | |
| JPH06502912A (ja) | アナライト変異体分析 | |
| CA2008304C (fr) | Dosage de la phosphatase alcaline des os | |
| US8241857B2 (en) | Method for detection of pneumococcus | |
| Koertge et al. | The relationship between the binding of primary antibody to solid-phase antigen in microtiter plates and its detection by the ELISA | |
| DK169571B1 (da) | Monoklont antistof, fremgangsmåde til dets fremstilling, hybridomcellelinie, der producerer antistoffet, fremgangsmåder til kvantitativ immunologisk bestemmelse af prokollagen-peptid (type III) med antistoffet, samt diagnostisk præparat indeholdende det monoklonale antistof | |
| CA1232849A (fr) | Antigenes circulants de dirofilaria immitis, anticorps monoclonaux specifiques et methodes de preparation desdits anticorps et de detection desdits antigenes | |
| Axiak et al. | Quantitation of free κ light chains in serum and urine using a monoclonal antibody based inhibition enzyme-linked immunoassay | |
| KR101062437B1 (ko) | 간흡충 특이 항원을 포함하는 간흡충증 진단 키트 및 상기간흡충 특이 항원의 생산을 위한 단클론 항체 | |
| US4752571A (en) | Method for determining certain bacterial polypeptides and antibodies directed against them | |
| US5679583A (en) | Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids | |
| CN115280146B (zh) | 包含人iv型胶原7s结构域的片段的测定方法以及用于该测定方法的试剂盒 | |
| US5094942A (en) | Detection of antibodies binding carboxypeptidase in serum of cancer patients | |
| Nielsen et al. | Interaction of specifically purified isotypes of bovine antibody to Brucella abortus in the haemolysis in gel test and enzyme-linked immunosorbent assay | |
| Hamilton et al. | Immunoradiometric assay for quantitation of Dirofilaria immitis antigen in dogs with heartworm infections | |
| Ali et al. | A computerized micro-ELISA assay for allergen-specific IgE antibodies | |
| US20110104823A1 (en) | Measuring lipoprotein containing particles | |
| EP1712564A1 (fr) | Anticorps monoclonal anti-nc1 | |
| Codington et al. | Immunologic quantitation of the carcinoma specific human carcinoma antigen in clinical samples | |
| ITVR960109A1 (it) | Immunopurificazione di un antigene dall'apparente peso molecolare di 16 +- 2 kda dell' helicobacter pylori e metodi per la sua determinazio | |
| KR101389945B1 (ko) | 신장암 혈액 바이오마커의 검출 방법 및 키트 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |